by Vandana Singh | Jan 8, 2026 | General
Enliven Therapeutics Inc. (NASDAQ:ELVN) stock is trading higher on Thursday, with a session volume of 6.61 million compared to the average volume of 631.52 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared encouraging initial...
by Lekha Gupta | Jan 8, 2026 | General
Fiserv, Inc. (NASDAQ:FISV) shares are trading higher on Thursday after the company disclosed a strategic deal with Microsoft Corporation (NASDAQ:MSFT) to accelerate AI integration across its development platforms. Details The collaboration aims to enhance...
by Vandana Singh | Jan 8, 2026 | General
MoonLake Immunotherapeutics (NASDAQ:MLTX) on Thursday received U.S. Food and Drug Administration (FDA) feedback regarding the clinical evidence strategy for Sonelokimab (SLK) in Hidradenitis Suppurativa (HS), based on the Type B meeting requested by MoonLake. SLK was...
by Khyathi Dalal | Jan 8, 2026 | General
Bitcoin is back above $90,000 on Thursday afternoon as crypto markets look to digest their early-year gains. CryptocurrencyTickerPriceBitcoin(CRYPTO: BTC)$90,922Ethereum(CRYPTO: ETH)$3,114Solana(CRYPTO: SOL)$138.03XRP(CRYPTO: XRP)$2.14Dogecoin(CRYPTO:...
by Vandana Singh | Jan 8, 2026 | General
Acrivon Therapeutics Inc. (NASDAQ:ACRV) on Thursday shared updates regarding the Phase 2 ACR-368 program and initial clinical data from the ACR-2316 Phase 1 study. ACR-368 Data In Arm 1 of the ACR-368 Phase 2b registrational-intent trial in endometrial cancer, an...
Recent Comments